Examination Report |
1 | Authorization Document (POA) | 24 Nov 2004 |
10 | TM-5 | 01 Jun 2010 |
11 | TM-5 | 17 Jun 2010 |
12 | Forwarding Letter for TM-5 | 29 Jun 2010 |
13 | Forwarding Letter for TM-5 | 30 Jun 2010 |
14 | TM-5 | 02 Jul 2010 |
15 | TM-44 | 02 Jul 2010 |
16 | Forwarding Letter for TM-5 | 19 Jul 2010 |
17 | Order | 08 Jun 2011 |
18 | Order | 15 Jul 2011 |
19 | Order | 04 Nov 2013 |
2 | Authorization Document (POA) | 14 Dec 2004 |
20 | Order | 11 Nov 2013 |
3 | Additional Representation Sheet | 06 Feb 2007 |
4 | TM-1 | 06 Feb 2007 |
5 | Examination Report | 18 Mar 2008 |
6 | Journal Copy | 01 Mar 2010 |
7 | Journal Copy | 01 Mar 2010 |
8 | TM-5 | 26 Apr 2010 |
9 | Forwarding Letter for TM-5 | 20 May 2010 |
The application for Brusol was made on 06 February 2007.
The trademark applicant for Brusol is GRANDIX PHARMACEUTICALS.
Brusol is applied in class(es) 5.
Application for Brusol is on Abandoned stage.
Application Id allotted to Brusol is 1528077.
Trademark agent or attorney for the application is Apr Associates.
Brusol filed with the Intellectual property office as a WORD.